New Preoperative Nomogram Using the Centrality Index to Predict High Nuclear Grade Clear Cell Renal Carcinoma

References

• Capitanio U, Montorsi F. Renal cancer. Lancet. 2015;387(10021 ):894. doi:10.1016/S0140-6736(15)00046-X26318520
   PubMed Web of Science ®Google Scholar
• Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37(10 ):1469–1489. doi:10.1097/PAS.0b013e318299f2d124025519
   PubMed Web of Science ®Google Scholar
• Tran T, Jones CL, Williamson SR, et al. Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma. Histopathology. 2016;68(6 ):850–857. doi:10.1111/his.2016.68.issue-626310887
   PubMed Web of Science ®Google Scholar
• Moch H. The WHO/ISUP grading system for renal carcinoma. Pathologe. 2016;37(4 ):355–360. doi:10.1007/s00292-016-0171-y27271258
   PubMed Web of Science ®Google Scholar
• Yuan Q, Kapur P, Zhang Y, et al. Intratumor heterogeneity of perfusion and diffusion in clear-cell renal cell carcinoma: correlation with tumor cellularity. Clin Genitourin Cancer. 2016;14(6 ):e585. doi:10.1016/j.clgc.2016.04.00727209349
   PubMed Web of Science ®Google Scholar
• Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol. 2010;185(6 ):2099.
   Google Scholar
• Zhu Y-H, Wang X, Zhang J, Chen Y-H, Kong W, Huang Y-R. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma. AJR Am J Roentgenol. 2014;203(3 ):295–300. doi:10.2214/AJR.13.12297
   Web of Science ®Google Scholar
• Huhdanpaa H, Hwang D, Cen S, et al. CT prediction of the fuhrman grade of clear cell renal cell carcinoma (RCC): towards the development of computer-assisted diagnostic method. Abdom Imaging. 2015;40(8 ):3168–3174. doi:10.1007/s00261-015-0531-826304585
   PubMedGoogle Scholar
• Ding J, Xing Z, Jiang Z, et al. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. Eur J Radiol. 2018;103:51–56. doi:10.1016/j.ejrad.2018.04.01329803385
   PubMed Web of Science ®Google Scholar
• Millet I, Doyon FC, Pages E, Thuret R, Taourel P. Morphometric scores for renal tumors: what does the radiologist need to know? Eur J Radiol. 2014;83(8 ):1303–1310. doi:10.1016/j.ejrad.2014.04.02524910263
   PubMed Web of Science ®Google Scholar
• Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3 ):844–853. doi:10.1016/j.juro.2009.05.03519616235
   PubMed Web of Science ®Google Scholar
• Ficarra V, Novara G, Secco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56(5 ):786–793. doi:10.1016/j.eururo.2009.07.04019665284
   PubMed Web of Science ®Google Scholar
• Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS. Kidney tumor location measurement using the C index method. J Urol. 2010;183(5 ):1708–1713. doi:10.1016/j.juro.2010.01.00520299047
   PubMed Web of Science ®Google Scholar
• Okhunov Z, R-B S, AK G, et al. The comparison of three renal tumor scoring systems: C-index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol. 2011;25(12 ):1921. doi:10.1089/end.2011.030121905850
   PubMed Web of Science ®Google Scholar
• Lipke MC, Ha SP, Fischer CD, Rydberg J, Bonsib SM, Sundaram CP. Pathologic characteristics of exophytic renal masses. J Endourol. 2007;21(12 ):1489–1491. doi:10.1089/end.2007.987418186688
   PubMed Web of Science ®Google Scholar
• Schachter LR, Bach AM, Snyder ME, Kattan MW, Russo P. The impact of tumour location on the histological subtype of renal cortical tumours. BJU Int. 2010;98(1 ):63–66. doi:10.1111/j.1464-410X.2006.06179.x
   Google Scholar
• Venkatesh R, Weld K, CD A, et al. Laparoscopic partial nephrectomy for renal masses: effect of tumor location. Urology. 2006;67(6 ):1169–1174. doi:10.1016/j.urology.2006.01.08916765174
   PubMed Web of Science ®Google Scholar
• Kutikov A, Smaldone MC, Egleston BL, et al. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL nephrometry score. Eur Urol. 2011;60(2 ):241–248. doi:10.1016/j.eururo.2011.03.02921458155
   PubMed Web of Science ®Google Scholar
• Delahunt B, Cheville JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37(10 ):1490. doi:10.1097/PAS.0b013e318299f0fb24025520
   PubMed Web of Science ®Google Scholar
• Delahunt B, Egevad L, Samaratunga H, Martignoni G, Nacey JN, Srigley JR. Gleason and Fuhrman no longer make the grade. Histopathology. 2016;68(4 ):475–481. doi:10.1111/his.2016.68.issue-426266664
   PubMed Web of Science ®Google Scholar
• Guðmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberge B. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish kidney cancer quality register data. Eur Urol. 2011;60(5 ):975–982. doi:10.1016/j.eururo.2011.06.02921741160
   PubMed Web of Science ®Google Scholar
• Powles T, Blank C, Chowdhury S, et al. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. Eur Urol. 2011;60(3 ):448–454. doi:10.1016/j.eururo.2011.05.02821612860
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Abe T, Matsumoto R, et al. Nephrometry score correlated with tumor proliferative activity inT1 clear cell renal cell carcinoma. Urol Oncol. 2019;37(5 ):301.e319–301.e325. doi:10.1016/j.urolonc.2019.02.005
   Web of Science ®Google Scholar
• Karakiewicz PI, Trinh QD, Riouxleclercq N, et al. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol. 2007;52(4 ):1140–1146. doi:10.1016/j.eururo.2007.01.07017336449
   PubMed Web of Science ®Google Scholar
• Chen SH, Wu YP, Li XD, et al. R.E.N.A.L. nephrometry score: a preoperative risk factor predicting the Fuhrman grade of clear-cell renal carcinoma. J Cancer. 2017;8(18 ):3725–3732. doi:10.7150/jca.2118929151960
   PubMed Web of Science ®Google Scholar
• Lam JS, Klatte T, Kim HL, et al. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol. 2008;65(3 ):235–262. doi:10.1016/j.critrevonc.2007.08.00317931881
   PubMed Web of Science ®Google Scholar
• Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 ):2217–2220. doi:10.1097/01.ju.0000095475.12515.5e14634382
   PubMed Web of Science ®Google Scholar
• Tsivian M, Mouraviev V, Albala DM, et al. Clinical predictors of renal mass pathological features. BJU Int. 2015;107(5 ):735–740. doi:10.1111/j.1464-410X.2010.09629.x
   Google Scholar
• Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol. 2009;181(1 ):29–34. doi:10.1016/j.juro.2008.09.00919012902
   PubMed Web of Science ®Google Scholar
• Orlhac F, Frouin F, Nioche C, Ayache N, Buvat I. Validation of a method to compensate multicenter effects affecting CT radiomics. Radiology. 2019;291(1 ):53–59. doi:10.1148/radiol.201918202330694160
   PubMed Web of Science ®Google Scholar
• Alsaikhan N, Alshehri W, Cassidy F, Aganovic L, Vahdat N. Renal tumor structured reporting including nephrometry score and beyond: what the urologist and interventional radiologist need to know. Abdom Radiol. 2018;1–11.
   PubMed Web of Science ®Google Scholar